|
|
Application effect of psychosocial intervention with adjuvant Zirazidone treatment in adolescent schizophrenia |
SONG Liu1 YU Suwei |
1.Department of Psychiatric,the Fourth People′s Hospital of Yingkou City,Liaoning Province,Yingkou 115000,China;
2.Department of Psychology,Yingkou First Specialized Hospital,Liaoning Province,Yingkou 115000,China |
|
|
Abstract Objective To explore the application effect of psychosocial intervention with adjuvant Zasidone treatment in adolescent schizophrenia (SCH).Methods A total of 88 adolescent schizophrenia SCH patients admitted to the Fourth People′s Hospital of Yingkou City from July 2019 to July 2020 were selected as the study subjects.They were divided into the drug group and the adjuvant intervention group according to random number table method,with 44 cases in each group.The drug group was treated with Zirasidone orally,while the adjuvant intervention group performed a psychosocial intervention on the basis of taking Zirasidone.The clinical efficacy,insight and social function before and after treatment were compared between the two groups.Results The total effective rate of the adjuvant intervention group after treatment was higher than that of the drug group,the difference was statistically significant (P<0.05).Before treatment,there were no significant differences in the social disability screening schedule (SDSS) score and the insight and treatment attitude questionnaire (ITAQ) scores between the two groups (P>0.05).After treatment,the scores of SDSS and ITAQ of the two groups were all lower than those before treatment,and the differences were statistically significant (P<0.05).The scores of SDSS and ITAQ of the adjuvant intervention group after treatment were lower than those in the drug group,and the differences were statistically significant (P<0.05).Conclusion For the adolescent children with SCH,psychosocial intervention with adjuvant Zirazidone treatment can improve their social function and self-knowledge state,and help to improve the clinical efficacy.
|
|
|
|
|
[1] |
王秀珍,孙太鹏,孙晖,等.男女儿童青少年精神分裂症患者临床特征的比较[J].临床精神医学杂志,2016,26(6):416-418.
|
[2] |
王慧,周娱菁,刘靖,等.青少年精神分裂症患者的健康相关危险行为[J].中国心理卫生杂志,2016,30(5):363-368.
|
[3] |
孙志刚,李素水,王灵君,等.齐拉西酮对首发精神分裂症患者认知功能影响的Meta 分析[J].中国健康心理学杂志,2017,25(7):115-121.
|
[4] |
胡春霞,王海龙.齐拉西酮与利培酮治疗首发儿童青少年精神分裂症对照研究[J].临床心身疾病杂志,2016,(1):52-54.
|
[5] |
王延祜,穆朝娟,刘兰芬.齐拉西酮及心理治疗对伴抑郁症状精神分裂症的临床研究[J].精神医学杂志,2015,28(6):433-436.
|
[6] |
陈柳利,许锦泉,陈健,等.齐拉西酮联合认知矫正治疗对青少年精神分裂症的疗效及对认知功能与社会功能的影响[J].临床医学,2021,41(1):61-63.
|
[7] |
徐枝楼,戴晓知,张素娟.综合心理行为干预对首发精神分裂症患者康复效果的影响[J].中华现代护理杂志,2014,20(19):2355-2359.
|
[8] |
张红燕,侯萍,时淑芳.齐拉西酮配合心理治疗用于精神分裂症抑郁症状疗效分析[J].中国现代医药杂志,2015,(8):87-88.
|
[9] |
王秀珍,孙太鹏,黄成兵,等.258 例儿童青少年精神分裂症住院患者药物治疗现状[J].国际精神病学杂志,2018,45(2):247-249.
|
[10] |
温亚平,郑克,刘洪杨.齐拉西酮和奥氮平治疗精神分裂症的疗效及对认知功能的影响[J].中国现代医生,2018,56(2):12-15.
|
[11] |
张美春,王滢霞.齐拉西酮治疗精神分裂症的疗效及对认知功能的影响分析[J].世界最新医学信息文摘(连续型电子期刊),2019,19(5):23-24.
|
[12] |
李辉.齐拉西酮对首发青少年精神分裂症患者脑神经功能和结构的影响[J].中国现代应用药学,2020,37(7):868-872.
|
[13] |
赵丽,冯竹娥,盛玉霞.齐拉西酮合并心理社会干预对儿童青少年精神分裂症的影响[J].蚌埠医学院学报,2018,43(5):621-623.
|
[14] |
于青,陈敏,翟金国,等.药物-心理-社会综合干预模式对精神分裂症患者结局的疗效[J].中华脑科疾病与康复杂志(电子版),2012,2(1):57-61.
|
[15] |
杨玲,谭成万,付艳梅,等.齐拉西酮联合心理干预在青少年精神分裂症中的应用效果[J].国际精神病学杂志,2017,44(5):794-796.
|
[16] |
袁素丽,朱春燕.综合心理治疗及干预对康复期精神分裂症患者社会功能的影响[J].中国现代医生,2019,57(26):143-146.
|
|
|
|